官方服务：
资源简介：
OVCAR8 cells treated with CDK12/13 inhibitiors (ZSQ836, THZ531, CR8)
应用场景：
创建时间：
2022-12-02
相关数据集
Additional file 11 of Machine learning approach informs biology of cancer drug response
Additional file 11. Supplementary Table S9. Top 20 GO Biological Processes enrichment of t-test derived genes for PTX analysis. P-values shown are corrected for multiple hypothesis testing using the H
NIAID Data Ecosystem60
Human TNBC Cells 72h Treatment with 4.5nM OTSSP167 MELK Inhibitor vs. DMSO Control (SUM159)
Microarray comparing TNBC cells treated for 72 hours with OTSSP167 MELK Inhibitor and control (DMSO) Two-condition arrays: SUM159 cells were treated with either 4.5nM OTSSP167 MELK Inhibitor or 0.045%
NIAID Data Ecosystem50
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination
T84 cells were treated with DMSO, 30nM trametinib (MEKi), 1µM JQ1 (BRD4i) or the combination of trametinib and JQ1 (combo) for 24h. Overall design: 3 replicates per condition were analyzed by RNA-seq
NIAID Data Ecosystem50
Structure of CDK12/CycK in complex with a small molecule inhibitor N-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)-N-((1r,4r)-4-(quinazolin-2-ylamino)cyclohexyl)acetamide
Structure of CDK12/CycK in complex with a small molecule inhibitor N-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)-N-((1r,4r)-4-(quinazolin-2-ylamino)cyclohexyl)acetamide Descriptor: Cyclin-K, Cyclin-dependent
Protein Data Bank Japan2024-11-06 更新50
